Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesSafety profile of dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed release formulation: global clinical trial experience
Alimentary Pharmacology and Therapeutics, 10/23/09
Peura DA et al. – Dexlansoprazole MR 30–90 mg has a safety profile comparable to that of lansoprazole.
Related Articles
Delayed release dexlansoprazole in the treatment of GERD and erosive esophagitis
Clinical and Experimental Gastroenterology, 11/17/09
Relevance Score: 87%
Dexlansoprazole MR
Expert Opinion in Pharmacotherapy, 10/19/09
Relevance Score: 85%
Clinical trial: efficacy and safety of dexlansoprazole MR 60 and 90 mg in healed erosive oesophagitis - maintenance of healing and symptom relief
Alimentary Pharmacology and Therapeutics, 10/09/09
Relevance Score: 83%
New Study Results Analyzed the Use of KAPIDEX (dexlansoprazole) for Nighttime Heartburn in Adults with Non-Erosive GERD
Internet Source, 10/28/09
Relevance Score: 80%
Today in Dosing...keeping you current
Receive free subspecialty "5-minute updates" via email
Drug-Drug Interaction Between Itraconazole and the Protease Inhibitor Lopinavir/Ritonavir
Annals of Pharmacotherapy, 11/25/09
Impact of pharmaceutical dosage form on stability and dissolution of roxithromycin
Central European Journal of Medicine, 11/24/09
Postoperative analgesia with minidose intrathecal morphine for bipolar hip prosthesis in extremely elderly patients
Journal of Anesthesia, 11/24/09
Today in Stomach/GI...keeping you current
Receive free subspecialty "5-minute updates" via email
Proton Pump Inhibitors and Pain
Pain Physician, 11/25/09
Clinical Features of Gastroduodenal Ulcer in Japanese Patients Taking Low-Dose Aspirin
Digestive Diseases and Sciences, 11/25/09
Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis
Cephalon, 11/24/09
Sponsor
Article Search
Sponsor